ÂÜÀòÂÒÂ×

Kristien Verhoeven is an accomplished executive with extensive experience in the clinical research and biotechnology sectors, currently serving as SVP and Global Business Unit Lead for Histopathology, Genomics, and Logistics at CellCarta since July 2021. Verhoeven has a strong track record in P&L management, achieving over 20% year-over-year revenue and EBITDA growth across multiple global sites. Previously, Verhoeven held the position of Chief Operating Officer at HistoGeneX, overseeing operational growth and integrating acquisitions. With a Ph.D. in Medical Sciences from the University of Antwerp and an MBA from the Antwerp Management School, Verhoeven combines scientific expertise with business acumen, driving value creation through operational efficiency, automation, and customer focus throughout a career that includes significant roles at Cochlear and VIB.